Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Jody Takemoto, PhD
Robert Wong, MD
An Exploration of Multiple Myeloma Treatments
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Jesus G. Berdeja, MD
Nicholas G. Barkemeyer, MPAS
Ajai Chari, MD
Harvey Church
Amy Gebhardt
Steven Morrow
MCED Testing: Confirming a Positive Result with Diagnostic Follow-Up
Brian P. McDonough, MD, FAAFP
Betsy O'Donnell, MD
Tomasz Beer, MD, FACP
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Geoffrey B. Johnson, M.D., Ph.D.
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Jennifer Caudle, DO
Diving into New Directions of Radiopharmaceuticals
Brianna Cagle
Highlighting the Current Status and Future of Theranostics
MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis
Nima Nabavizadeh, MD
A Look at the Horizon of Cancer Vaccines
Lillian Siu, MD, FRCPC
A Unique Look at the Current and Future Directions of Cancer Vaccines
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
Samuel J. Klempner, MD
Patients with HER2-low mBC: Discussing the Unmet Needs and Potential Improvements
Pavani Chalasani, MD, MPH
Virginia Kaklamani, MD
The Power of Patient Advocacy in Daily Clinical Practice
Ashley L. Sumrall, MD
HER2+ Metastatic Breast Cancer Therapies: Managing Adverse Events
Megan Kruse, MD
Caring for HER2+ mBC Patients Through Collaboration and Communication
Marcela Mazo Canola, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.